Will Chevron Acquire Hess?
Long-time Buffett favorite in the energy sector Chevron (NYSE:CVX) is…
Sell
39
MRNA Quote, Financials, Valuation and Earnings
Last price:
$33.87
Seasonality move
:
17.67%
Day range:
$32.80 - $34.87
52-week range:
$29.25 - $170.47
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
4.14x
P/B ratio:
1.21x
Volume:
10.5M
Avg. volume:
11.2M
1-year change:
-67.59%
Market cap:
$13.2B
Revenue:
$3.2B
EPS (TTM):
-$9.28
Earnings Data
Next earnings date for MRNA
May 02
2025
Most recent earnings per share
-$2.91
Missed by $0.18
(Feb 14/2025)
Consensus Estimate
-$2.73
(Feb 14/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
MRNA Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 05/02/2025 | Q1 | $130.3M | -- | -- | -$3.07 | -- |
| 02/14/2025 | Q4 | $941.1M | $956M | -$2.91 | -$2.73 | -$0.18 |
| 11/07/2024 | Q3 | $1.2B | $1.9B | $0.03 | -$1.94 | $1.97 |
| 08/01/2024 | Q2 | $134.9M | $221M | -$3.33 | -$3.36 | $0.03 |
| 05/02/2024 | Q1 | $125.3M | $167M | -$3.07 | -$3.55 | $0.48 |
| 02/22/2024 | Q4 | $2.5B | $2.8B | $0.55 | -$0.99 | $1.54 |
| 11/02/2023 | Q3 | -- | -- | -$9.53 | -$2.05 | -$7.48 |
| 06/30/2023 | Q2 | -- | -- | -$3.62 | -$4.12 | $0.50 |
| 03/31/2023 | Q1 | -- | -- | $0.19 | -$1.73 | $1.92 |
| 12/31/2022 | Q4 | -- | -- | $3.61 | $4.60 | -$0.99 |
| 09/30/2022 | Q3 | -- | -- | $2.53 | $3.11 | -$0.58 |
| 06/30/2022 | Q2 | -- | -- | $5.24 | $4.49 | $0.75 |
| 03/31/2022 | Q1 | -- | -- | $8.58 | -- | -- |
| 12/31/2021 | Q4 | -- | -- | $11.29 | -- | -- |
| 09/30/2021 | Q3 | -- | -- | $7.70 | -- | -- |
| 06/30/2021 | Q2 | -- | -- | $6.46 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | $2.84 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$0.69 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$0.59 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$0.31 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$0.35 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | -$0.37 | -- | -- |
| 09/30/2019 | Q3 | -- | -- | -$0.37 | -- | -- |
| 06/30/2019 | Q2 | -- | -- | -$0.41 | -- | -- |
| 03/31/2019 | Q1 | -- | -- | -$0.40 | -- | -- |
| 12/31/2018 | Q4 | -- | -- | -$0.43 | -- | -- |
| 09/30/2018 | Q3 | -- | -- | -$0.27 | -- | -- |
| 06/30/2018 | Q2 | -- | -- | -$0.24 | -- | -- |
| 03/31/2018 | Q1 | -- | -- | -$0.19 | -- | -- |
| 12/31/2017 | Q4 | -- | -- | -$0.10 | -- | -- |
Moderna Earnings Questions
-
How Much did Moderna Generate in Revenue Last Quarter?
Moderna reported $956M worth of top line sales in its most recent quarter.
-
Did Moderna Beat Earnings Last Quarter?
Moderna announced earnings per share of -$2.91 which represents a miss of analyst forecast a -$2.73 per share.
-
Is Moderna Profitable?
Moderna reported $217M that represents $0.56 per share over the last quarter.
-
What is the Analyst Consensus for Moderna EPS Next Year?
Moderna's earnings are forecast to decrease from -$9.28 per share to -$9.03 per share next year representing a decrease of -11.15%.
-
When is Moderna's Earnings Date?
Moderna's next earnings date is May 2, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Progressive Stock Go Down?
Shares of insurance giant Progressive (NYSE:PGR) have fallen considerably over…
Why Did StoneCo Stock Go Up So Much?
Brazilian fintech company StoneCo (NASDAQ:STNE) has been on a tear…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3T
P/E Ratio: 41x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Sell
47
RGC alert for Mar 25
Regencell Bioscience Holdings [RGC] is up 4.9% over the past day.
Buy
54
AZEK alert for Mar 25
The AZEK [AZEK] is up 1.01% over the past day.
Sell
36
MPTI alert for Mar 25
M-Tron Industries [MPTI] is up 7.48% over the past day.
